Long-Term Immunity and Booster Strategies for COVID-19 Vaccines
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 97
Special Issue Editors
Interests: clinical infectious diseases; clinical virology; immune response following mRNA SRAR-CoV-2 vaccines
Special Issue Information
Dear Colleagues,
As the COVID-19 pandemic evolves into a persistent endemic threat, vaccination strategies must adapt accordingly. While the repeat dosing of updated mRNA vaccines continues to be recommended, recent evidence suggests that a one-size-fits-all approach may no longer be appropriate. For individuals at high risk (those aged 65 years and older, immunocompromised individuals, or those with major comorbidities), the benefit-risk profile of continued vaccination remains favorable and widely accepted. However, the optimal approach for non-high-risk subjects is far less clear.
Accumulating immunologic and clinical data suggests substantial heterogeneity in vaccine-induced protection, influenced by prior infection history, immune imprinting, previous vaccine doses received, and breakthrough infections caused by emerging SARS-CoV-2 variants. Moreover, in individuals who are young, healthy, and previously vaccinated or infected, the marginal benefit of additional vaccine doses remains uncertain. Therefore, there is a need for more targeted and evidence-based vaccination strategies designed for non-high-ridsk individuals.
This Special Issue invites original research and reviews from both basic science and clinical studies to address the long-term dynamics of immunity to SARS-CoV-2 following vaccination and critically evaluate booster strategies for non-high-risk individuals. Topics of interest include immune imprinting, hybrid immunity, correlates of protection, variant-specific vaccine responses, and public health implications of risk-stratified vaccination. By assembling this body of work, we aim to obtain useful evidence that could help building rational, individualized vaccination policies for SARS-CoV-2 for the large population of non-high-risk individuals.
Dr. Alejo Erice
Prof. Dr. Ortiz De Lejarazu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- mRNA vaccines
- long-term immunity
- immune imprinting
- hybrid immunity
- booster strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
